The Lancet Gastroenterology & Hepatology in conversation with

Rupert Leong on oral faecal microbiota transplantation in ulcerative colitis

The Lancet Gastroenterology & Hepatology

Rupert Leong (University of Sydney) discusses a new double-blind, randomised, placebo-controlled trial of oral faecal microbiota transplantation for patients with active ulcerative colitis.

Read the full article:
Lyophilised oral faecal microbiota transplantation for ulcerative colitis (LOTUS)

Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv